Results 71 to 80 of about 178,280 (162)

Marathons and myasthenia gravis: a case report

open access: yesBMC Neurology, 2018
Background The cardinal symptoms of auto-immune myasthenia gravis are fatigue and weakness. Endurance events such as marathon running would seem incompatible with this chronic disease. Many patients stop sport altogether.
Simone Birnbaum   +5 more
doaj   +1 more source

Miasthenia gravis in pediatric age

open access: yesActa Médica del Centro, 2008
Background: Myasthenia gravis is an autoimmune disorder characterized by fluctuating muscle weakness and fatigue of different muscle groups, secondary to a synaptic transmission alteration caused by the blockade and destruction of the acetylcholine ...
Liubka María Pérez Mederos   +3 more
doaj  

Pure Ocular Myasthenia gravis

open access: yes, 2018
Pure ocular myasthenia was always described as a separate entity in historical publications. More than 50% of patients develop generalized symptoms in the course of the disease.
Sophie Schötz   +2 more
core   +1 more source

Comitant Ocular Deviation in Myasthenia Gravis

open access: yes, 2021
Occurrence of comitant ocular deviation in myasthenia gravis (MG) is not well ...
Tiffany Pike-Lee, MD; Jeremy Hill, MD; Jianbo Li, PhD; Gregory S. Kosmorsky, DO; Yuebing Li, MD, PhD
core  

Anaesthetic Management of Myasthenia Gravis with Thymic Mass in Facial Trauma [PDF]

open access: yes, 2010
Myasthenia gravis is an immunologic disorder characterised by polyclonal antibodies directed against nicotinic acetylcholine receptors at postneuromuscular junction.
Dheer Singh, Deepak Sharma
core  

Comparison of diagnostic tests in myasthenia gravis

open access: yes, 1983
Results of 3 tests, intravenous edrophonium chloride, EMG, and acetylcholine receptor antibody testing, were compared in patients with generalised and ocular myasthenia gravis.
Nicholson, G. A.   +2 more
core  

An Atypical Case of Myasthenia Gravis: Purely Bulbar in a Young Male

open access: yesMcGill Journal of Medicine, 2020
Myasthenia Gravis (MG), an uncommon autoimmune syndrome caused by the failure of neuromuscular transmission, results from bind- ing of autoantibodies to proteins that are involved in signaling at the neuromuscular junction (1).
Muhammad Amer Saleem   +3 more
doaj  

The Anti-Acetylcholine Receptor Antibody Test in Suspected Ocular Myasthenia Gravis

open access: yesJournal of Ophthalmology, 2014
Aim. To estimate the clinical significance of anti-acetylcholine receptor antibody (anti-AChR-Ab) levels in suspected ocular myasthenia gravis. Methods. In total, 144 patients complaining of fluctuating diplopia and ptosis were evaluated for serum levels
Jung Jin Lee   +2 more
doaj   +1 more source

Ocular Myasthenia Gravis: Controversies and Updates

open access: yesCurrent Neurology and Neuroscience Reports, 2013
The majority of patients with myasthenia gravis (MG) initially present with ocular symptoms. An unresolved question is whether there are clinical features at onset to guide clinicians to predict an individual patient's conversion risk from ocular MG (OMG) to generalized disease, or "secondary generalized MG" (SGMG), that is, a prognostic model.
Wong, S, Huda, S, Vincent, A, Plant, G
openaire   +3 more sources

Ocular Myasthenia Gravis

open access: yes, 2019
Dr.
Andrew G. Lee, MD; Pauline Berens
core  

Home - About - Disclaimer - Privacy